• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > GlaxoSmithKline > November 30, 2010

      GSK & JSC Binnopharm enter vaccine production alliance in Russia

      Posted Atpharmabiz.com

      GlaxoSmithKline (GSK) and JSC Binnopharm announced an alliance to enable the local secondary manufacture of a number of GSK vaccines in Russia. The agreement was signed in Moscow during the session of the Russian-British Intergovernmental Steering Committee (ISC) for Trade and Investment.

      Under this alliance, GSK will supply bulk vaccine and provide technology and expertise to enable Binnopharm to undertake the secondary manufacture, including filling and packaging of a number of innovative GSK vaccines in accordance with international current Good Manufacturing Practice (cGMP) standards. Binnopharm will be responsible for gaining approval of their facilities to allow supply of GSK cervical cancer, rotavirus and pneumococcal vaccines under Binnopharm's trademark for the Russian public market.

      The local manufacture of these vaccines should help Russia to modernise its National Immunisation Calendar in the future, adding additional vaccination against highly prevalent infections such as Human Papillomavirus (HPV), rotavirus and Streptococcus pneumoniae.

      GSK will book sales of the bulk vaccine supplied to Binnopharm through this alliance. No further financial details of the agreement have been disclosed.

      Commenting on the agreement, Abbas Hussain, president, Emerging Markets & Asia Pacific, GSK said, "This agreement is an example of the flexible approach we are taking to make innovative vaccines more available in emerging markets through local partnerships. GSK has one of the broadest and fastest growing vaccines businesses in the world. This alliance with Binnopharm should ensure that more of these innovative vaccines are made available in Russia to benefit public health."

      Maxim Uvarov, General Manager, Binnopharm said: "The prompt implementation of this joint project between Binnopharm and GSK is a testament to the continued investment in our existing facilities and the quality of the Russian staff and management who have worked efficiently to create an international and innovative business partnership. Our aim through signing this partnership agreement is to create a leading biotechnology company in Russia."

      Dr Vince Cable, UK Secretary of State for Business, Innovation and Skills added: "GlaxoSmithKline's alliance with Binnopharm shows just what can be accomplished when companies work together to achieve their goals. Not only does this demonstrate trust between companies sharing their knowledge across borders, but ordinary people will see the benefits. As a result, there will be more locally manufactured vaccines available in Russia covering illnesses from pneumonia through to HPV. This is a very positive outcome and one which emphasises the strong pharmaceutical links that the UK shares with Russia."

      GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

      Binnopharm is one of the largest biotechnological and pharmaceutical complexes in Russia (more than 32 thous. m2) with the largest in Russia biotech medicines manufacture, complete production cycle in accordance with GMP (Good Manufacturing Practice) standards. It is equipped with multipurpose production lines for the production of tablets, capsules, ampoules, sprays, aerosols.

      Nov 30, 2010


       

      Share this Article!

    Back to top^